Mimedx (MDXG) Total Debt (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.08% |
| Dec 31, 2025 | -1.36% |
| Sep 30, 2025 | -1.34% |
| Jun 30, 2025 | -1.06% |
| Mar 31, 2025 | -0.91% |
| Dec 31, 2024 | -0.99% |
| Sep 30, 2024 | -7.00% |
| Jun 30, 2024 | 5.12% |
| Mar 31, 2024 | -60.38% |
| Dec 31, 2023 | 0.27% |
| Sep 30, 2023 | 0.26% |
| Jun 30, 2023 | 0.25% |
| Mar 31, 2023 | 0.25% |
| Dec 31, 2022 | 0.25% |
| Sep 30, 2022 | 0.25% |
| Jun 30, 2022 | 0.24% |
| Mar 31, 2022 | 0.23% |
| Dec 31, 2021 | 0.23% |
| Sep 30, 2021 | 0.23% |
| Jun 30, 2021 | 0.22% |
| Mar 31, 2021 | 0.21% |
| Dec 31, 2020 | 0.15% |
| Sep 30, 2020 | -26.98% |
| Jun 30, 2020 | -0.25% |
| Mar 31, 2020 | -0.41% |
| Dec 31, 2019 | -0.41% |
| Sep 30, 2019 | -1.34% |
| Jun 30, 2017 | 101.08% |
| Mar 31, 2017 | 5.81% |
| Dec 31, 2016 | -14.33% |
| Sep 30, 2016 | 0.00% |
| Sep 30, 2012 | -42.52% |
| Jun 30, 2012 | 14.81% |
| Mar 31, 2012 | -26.64% |
| Dec 31, 2011 | 91.18% |
| Sep 30, 2011 | 16,363.45% |